Skip to content
The Longevity Archive
Amycretin in all countries

Legal status · United Kingdom

Is Amycretin legal in the United Kingdom?

InvestigationalMetabolicEvidence: Moderate

No. Amycretin is not approved for any medical use in the United Kingdom; its classification is "Investigational, not licensed". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Moderate.

Amycretin in the United Kingdom at a glance

ClassificationInvestigational, not licensed
MHRA approval statusNot approved by MHRA; investigational
Evidence levelModerate (research strength: Moderate)
ReviewedSep 2026

Classification and note come from the Amycretin profile, checked against Medicines and Healthcare products Regulatory Agency (MHRA) listings at the reviewed date.

What this means

  • 01

    Amycretin is being studied in registered clinical trials but has not received MHRA marketing approval in the United Kingdom.

  • 02

    Lawful human access is limited to trial participation or a formal early-access scheme where one exists; there is no pharmacy product to prescribe.

  • 03

    Vials sold online "for research use only" are not trial material, and that label does not make human use lawful.

What Amycretin is

Novo Nordisk's single-molecule GLP-1 and amylin agonist, in oral and injectable forms, that showed strong early weight loss and is heading to Phase 3.

Amycretin is a Novo Nordisk drug that combines GLP-1 and amylin activity in a single molecule, aiming to match combination therapy in one agent. It is being developed in both oral and injectable forms.

Mechanism: A single molecule that agonizes both the GLP-1 and amylin receptors to suppress appetite through two complementary pathways.

Regulatory history: Investigational (Phase 3 AMAZE program started February 2026)

How MHRA treats this kind of product

Licenses medicines for the UK market. A compound without a marketing authorisation is an unlicensed medicine, which can only lawfully be supplied for human use through a prescriber under the specials scheme, not sold as a research product.

The classification above is the The Longevity Archive reading of Medicines and Healthcare products Regulatory Agency listings for Amycretin at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.

Amycretin in other countries

Frequently asked questions

Is Amycretin legal in the United Kingdom?

No. Amycretin is not approved for any medical use in the United Kingdom; its classification is "Investigational, not licensed". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Moderate.

Can I buy Amycretin in the United Kingdom?

No approved product exists to buy. In the United Kingdom Amycretin is classified as "Investigational, not licensed", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.

Is Amycretin MHRA approved?

No. In the United Kingdom Amycretin is classified as "Investigational, not licensed", which is not a MHRA marketing approval. For comparison, the US FDA status is: Investigational (Phase 3 AMAZE program started February 2026). Evidence level: Moderate.

Related compounds in the United Kingdom

Full research profile

Mechanism, cited studies, FDA status and the full legal summary for Amycretin live on its compound profile.

Amycretin profile

This page is general information about the regulatory status of Amycretin in the United Kingdom, current as of Sep 2026. It is not legal advice, and classifications change; check Medicines and Healthcare products Regulatory Agency directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.